Work

Oral Dosage Forms of Catalase Associated with Probiotics Using Carboxymethylcellulose and Carboxymethylstarch: A Potential Approach for Intestinal Inflammation

Year: 2026
Type: article
Abstract: Inflammatory bowel diseases frequently associated with oxidative stress phenomena represent an important component of intestinal inflammation. An excess of hydrogen peroxide (H2O2) is mucosa damaging, and its removal becomes a therapeutic strategy. The oral administration of antioxidant enzymes such as catalase remains challenging because enzyme activity can be rapidly impaired under gastric conditions. Carboxymethylcellulose (CMC)- and carboxymethylstarch (CMS)-based tablets for oral delivery of catalase were investigated. Tablets containing 30% (w/w) catalase were exposed for 2 h to simulated gastric fluid (SGF) followed by 5 h in simulated intestinal fluid (SIF). Approximately 58% of the initial catalase activity was recovered from the CMC-based tablets, and about 44% from the CMS-based tablets. Despite this partial recovery, both formulations retained sufficient functional activity to achieve near-complete degradation of 5 mM H2O2 in vitro within 240 min for CMC and 300 min for CMS. The incorporation of cross-linked starch improved the mechanical strength of the CMC-based tablets and maintained the percentage of catalase recovery. The association of catalase and probiotics within the same formulation was also examined. The co-formulated catalase–probiotics maintained bacterial viability following 2 h of gastric exposure and 5 h in SIF. The presence of catalase did not compromise the bacterial viability. It appears that such a system could provide a basis for future strategies simultaneously targeting intestinal oxidative stress and microbiota imbalance.
Language: English
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7235867565
FWCI:
Cites: 31
Cited by:
Related to: 10